• 2026.03.09Timely Disclosure
  Announcement of Adoption of Japan Agency for Medical Research and Development (AMED)’s FY2026 “Project Promoting Clinical Trials for Development of New Drugs”: Phase II Study for Non-Small Cell Lung Cancer(168KB)
• 2026.03.05Timely Disclosure
  Preliminary results of a Phase II study with nivolumab and PAI-1 inhibitor (RS5614) combination therapy for non-small cell lung cancer(167KB)
• 2026.03.04Timely Disclosure
  Breaking News: Completion of A Multicenter Clinical Trial of Disposable Ultrafine Endoscope for Peritoneal Dialysis(178KB)
• 2026.03.03Timely Disclosure
  Announcement of Agreement of the Tohoku University – University College London Matching Fund: Diabetes Treatment Support Program Medical Device(147KB)
• 2026.02.13Financial Statements
  Non-consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)(194KB)

IR News List